Characterization of the expression of the pro-metastatic MenaINV isoform during breast tumor progression

Madeleine J. Oudin, Shannon K. Hughes, Nazanin Rohani, Mira N. Moufarrej, Joan G. Jones, John S. Condeelis, Douglas A. Lauffenburger, Frank B. Gertler

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Several functionally distinct isoforms of the actin regulatory Mena are produced by alternative splicing during tumor progression. Forced expression of the MenaINV isoform drives invasion, intravasation and metastasis. However, the abundance and distribution of endogenously expressed MenaINV within primary tumors during progression remain unknown, as most studies to date have only assessed relative mRNA levels from dissociated tumor samples. We have developed a MenaINV isoform-specific monoclonal antibody and used it to examine MenaINV expression patterns in mouse mammary and human breast tumors. MenaINV expression increases during tumor progression and to examine the relationship between MenaINV expression and markers for epithelial or mesenchymal status, stemness, stromal cell types and hypoxic regions. Further, while MenaINV robustly expressed in vascularized areas of the tumor, it is not confined to cells adjacent to blood vessels. Altogether, these data demonstrate the specificity and utility of the anti-MenaINV-isoform specific antibody, and provide the first description of endogenous MenaINV protein expression in mouse and human tumors.

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalClinical and Experimental Metastasis
DOIs
StateAccepted/In press - Dec 17 2015

Fingerprint

Protein Isoforms
Breast Neoplasms
Neoplasms
Alternative Splicing
Stromal Cells
Blood Vessels
Actins
Breast
Monoclonal Antibodies
Neoplasm Metastasis
Messenger RNA
Antibodies
Proteins

Keywords

  • Breast cancer
  • Hypoxia
  • Mena
  • Metastasis
  • Microenvironment
  • Stemness

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Characterization of the expression of the pro-metastatic MenaINV isoform during breast tumor progression. / Oudin, Madeleine J.; Hughes, Shannon K.; Rohani, Nazanin; Moufarrej, Mira N.; Jones, Joan G.; Condeelis, John S.; Lauffenburger, Douglas A.; Gertler, Frank B.

In: Clinical and Experimental Metastasis, 17.12.2015, p. 1-13.

Research output: Contribution to journalArticle

Oudin, Madeleine J. ; Hughes, Shannon K. ; Rohani, Nazanin ; Moufarrej, Mira N. ; Jones, Joan G. ; Condeelis, John S. ; Lauffenburger, Douglas A. ; Gertler, Frank B. / Characterization of the expression of the pro-metastatic MenaINV isoform during breast tumor progression. In: Clinical and Experimental Metastasis. 2015 ; pp. 1-13.
@article{0723cf0dec73499c9b4380723dc2d632,
title = "Characterization of the expression of the pro-metastatic MenaINV isoform during breast tumor progression",
abstract = "Several functionally distinct isoforms of the actin regulatory Mena are produced by alternative splicing during tumor progression. Forced expression of the MenaINV isoform drives invasion, intravasation and metastasis. However, the abundance and distribution of endogenously expressed MenaINV within primary tumors during progression remain unknown, as most studies to date have only assessed relative mRNA levels from dissociated tumor samples. We have developed a MenaINV isoform-specific monoclonal antibody and used it to examine MenaINV expression patterns in mouse mammary and human breast tumors. MenaINV expression increases during tumor progression and to examine the relationship between MenaINV expression and markers for epithelial or mesenchymal status, stemness, stromal cell types and hypoxic regions. Further, while MenaINV robustly expressed in vascularized areas of the tumor, it is not confined to cells adjacent to blood vessels. Altogether, these data demonstrate the specificity and utility of the anti-MenaINV-isoform specific antibody, and provide the first description of endogenous MenaINV protein expression in mouse and human tumors.",
keywords = "Breast cancer, Hypoxia, Mena, Metastasis, Microenvironment, Stemness",
author = "Oudin, {Madeleine J.} and Hughes, {Shannon K.} and Nazanin Rohani and Moufarrej, {Mira N.} and Jones, {Joan G.} and Condeelis, {John S.} and Lauffenburger, {Douglas A.} and Gertler, {Frank B.}",
year = "2015",
month = "12",
day = "17",
doi = "10.1007/s10585-015-9775-5",
language = "English (US)",
pages = "1--13",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Characterization of the expression of the pro-metastatic MenaINV isoform during breast tumor progression

AU - Oudin, Madeleine J.

AU - Hughes, Shannon K.

AU - Rohani, Nazanin

AU - Moufarrej, Mira N.

AU - Jones, Joan G.

AU - Condeelis, John S.

AU - Lauffenburger, Douglas A.

AU - Gertler, Frank B.

PY - 2015/12/17

Y1 - 2015/12/17

N2 - Several functionally distinct isoforms of the actin regulatory Mena are produced by alternative splicing during tumor progression. Forced expression of the MenaINV isoform drives invasion, intravasation and metastasis. However, the abundance and distribution of endogenously expressed MenaINV within primary tumors during progression remain unknown, as most studies to date have only assessed relative mRNA levels from dissociated tumor samples. We have developed a MenaINV isoform-specific monoclonal antibody and used it to examine MenaINV expression patterns in mouse mammary and human breast tumors. MenaINV expression increases during tumor progression and to examine the relationship between MenaINV expression and markers for epithelial or mesenchymal status, stemness, stromal cell types and hypoxic regions. Further, while MenaINV robustly expressed in vascularized areas of the tumor, it is not confined to cells adjacent to blood vessels. Altogether, these data demonstrate the specificity and utility of the anti-MenaINV-isoform specific antibody, and provide the first description of endogenous MenaINV protein expression in mouse and human tumors.

AB - Several functionally distinct isoforms of the actin regulatory Mena are produced by alternative splicing during tumor progression. Forced expression of the MenaINV isoform drives invasion, intravasation and metastasis. However, the abundance and distribution of endogenously expressed MenaINV within primary tumors during progression remain unknown, as most studies to date have only assessed relative mRNA levels from dissociated tumor samples. We have developed a MenaINV isoform-specific monoclonal antibody and used it to examine MenaINV expression patterns in mouse mammary and human breast tumors. MenaINV expression increases during tumor progression and to examine the relationship between MenaINV expression and markers for epithelial or mesenchymal status, stemness, stromal cell types and hypoxic regions. Further, while MenaINV robustly expressed in vascularized areas of the tumor, it is not confined to cells adjacent to blood vessels. Altogether, these data demonstrate the specificity and utility of the anti-MenaINV-isoform specific antibody, and provide the first description of endogenous MenaINV protein expression in mouse and human tumors.

KW - Breast cancer

KW - Hypoxia

KW - Mena

KW - Metastasis

KW - Microenvironment

KW - Stemness

UR - http://www.scopus.com/inward/record.url?scp=84949975966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949975966&partnerID=8YFLogxK

U2 - 10.1007/s10585-015-9775-5

DO - 10.1007/s10585-015-9775-5

M3 - Article

C2 - 26680363

AN - SCOPUS:84949975966

SP - 1

EP - 13

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

ER -